Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Charly Gutierrez"'
Autor:
Athanasia Liabotis, Corinne Ardidie-Robouant, Philippe Mailly, Samaher Besbes, Charly Gutierrez, Yoann Atlas, Laurent Muller, Stéphane Germain, Catherine Monnot
Publikováno v:
Biomedicines, Vol 10, Iss 2, p 206 (2022)
Angiopoietin-like 4 (ANGPTL4) is a target of hypoxia that accumulates in the endothelial extracellular matrix. While ANGPTL4 is known to regulate angiogenesis and vascular permeability, its context-dependent role related to vascular endothelial growt
Externí odkaz:
https://doaj.org/article/159152695c0644e49df0f40fdb61c507
Autor:
Charly Gutierrez, Xavier Pinson, Kathleen Jarnouen, Marine Charpentier, Raphael Pineau, Laëtitia Lallement, Rémy Pedeux
Publikováno v:
Cancers; Volume 14; Issue 9; Pages: 2171
Cancers
Cancers, 2022, 14 (9), pp.2171. ⟨10.3390/cancers14092171⟩
Cancers
Cancers, 2022, 14 (9), pp.2171. ⟨10.3390/cancers14092171⟩
International audience; Urine cytology is non-invasive, easy to collect, with medium sensitivity and a high specificity. It is an effective way to detect high-grade bladder cancer (BC), but it is less effective on low-grade BC because the rate of equ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fe253bbe3aa7eaedc0d724a92c4b64c
https://pubmed.ncbi.nlm.nih.gov/35565300
https://pubmed.ncbi.nlm.nih.gov/35565300
Autor:
Athanasia Liabotis, Corinne Ardidie-Robouant, Philippe Mailly, Samaher Besbes, Charly Gutierrez, Yoann Atlas, Laurent Muller, Stéphane Germain, Catherine Monnot
Publikováno v:
Biomedicines; Volume 10; Issue 2; Pages: 206
Biomedicines
Biomedicines, 2022, 10 (2), pp.206. ⟨10.3390/biomedicines10020206⟩
Biomedicines
Biomedicines, 2022, 10 (2), pp.206. ⟨10.3390/biomedicines10020206⟩
Angiopoietin-like 4 (ANGPTL4) is a target of hypoxia that accumulates in the endothelial extracellular matrix. While ANGPTL4 is known to regulate angiogenesis and vascular permeability, its context-dependent role related to vascular endothelial growt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::652d908a3d9ef2eb16acb352c04f2094
https://pubmed.ncbi.nlm.nih.gov/35203415
https://pubmed.ncbi.nlm.nih.gov/35203415
Publikováno v:
Cancers
Cancers, MDPI, 2021, 13 (7), ⟨10.3390/cancers13071650⟩
Cancers, 2021, 13 (7), ⟨10.3390/cancers13071650⟩
Cancers, Vol 13, Iss 1650, p 1650 (2021)
Cancers, MDPI, 2021, 13 (7), ⟨10.3390/cancers13071650⟩
Cancers, 2021, 13 (7), ⟨10.3390/cancers13071650⟩
Cancers, Vol 13, Iss 1650, p 1650 (2021)
Simple Summary Bladder cancer (BC) is the tenth most common cancer worldwide, with approximatively 550,000 new cases and 200,000 deaths in 2018. BC is divided into two subgroups: non-muscle invasive bladder cancer, an early stage of the cancer, and m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::4c889c4be61bef7b3119f6ae4a749e18
https://hal.archives-ouvertes.fr/hal-03215764
https://hal.archives-ouvertes.fr/hal-03215764
